Center for Pacific Innovations, Knowledge, and Opportunities (PIKO)
太平洋创新、知识和机会中心 (PIKO)
基本信息
- 批准号:10281542
- 负责人:
- 金额:$ 300万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptionAffectAsiansBiometryBudgetsCOVID-19COVID-19 pandemicClinical InvestigatorClinical ResearchCommunicationCommunitiesCommunity OutreachDataData ScienceDeath RateDevelopmentDissemination and ImplementationDoctor of PhilosophyEconomicsEnsureEnvironmentEthnic groupEvaluationFaceFilipinoFosteringFundingGap JunctionsHawaiiHawaiian populationHealthHealth PersonnelHealth PromotionHomelessnessHumanIndigenousInstitutionInstitutionalizationInterventionInvestmentsKnowledgeLeadLeftLongevityMental HealthMentorsNative HawaiianPacific Island AmericansParticipantPersonal SatisfactionPilot ProjectsPoliciesPopulationPovertyRegistriesResearchResearch ActivityResearch DesignResearch InfrastructureResearch PersonnelResourcesRuralScienceSexual and Gender MinoritiesShockTranslational ResearchTrustUnderinsuredUnderserved PopulationUnemploymentUninsuredUnited StatesUnited States National Institutes of HealthUniversitiesVulnerable Populationsbasecareerclinical developmentcommunity engagementcommunity organizationsdisorder preventiondissemination strategyefficacy studyepidemiology studyevidence basehealth care availabilityhealth disparityhealth disparity populationsimplementation strategyimprovedinnovationmedically underserved populationmentoring communityoperationphysical conditioningprogramsracial and ethnicresearch studyrural areasocial health determinantssocioeconomicssuccesssymposiumunderserved communityunhealthy lifestyleuser-friendly
项目摘要
The Center for Pacific Innovations, Knowledge, and Opportunities (PIKO) will build a statewide clinical and
translational research (CTR) infrastructure to improve the health of Indigenous Pacific People (IPP) – defined as
Native Hawaiians, Other Pacific Islanders, and Filipinos. IPP comprise 40% of Hawaii’s population and have
disproportionately high rates of physical and mental health conditions compared to Whites and Asians. They
also make up a majority of Hawaii’s other medically underserved and vulnerable populations. PIKO represents
a partnership between the University of Hawaii (lead), Hawaii Pacific University, Chaminade University of
Honolulu, and a statewide network of practice-based organizations (PBO) and community-based organizations
(CBO). PIKO emphasizes the T3 (efficacy studies) to T5 (adoption and institutionalization) domains of CTR
where the social determinants of health are strongly operative. PIKO takes a team-science approach to transform
current CTR paradigms and to accelerate CTR advances to improve IPP health. PIKO comprises seven Cores:
Administrative; Professional Development; Pilot Projects Program; Biostatistics, Epidemiology, and Research
Design; Community Engagement and Outreach; Clinical Research and Regulatory Support; and Tracking and
Evaluation. The University of Hawaii committed $2 million over 5 years to PIKO. The Overall Specific Aims are:
Specific Aim 1: Build a robust CTR infrastructure by establishing and implementing CTR activities within
and across PIKO partnering institutions; by leveraging resources and expertise of other research infrastructure
programs; by creating CTR registries of academic mentors, community leaders, junior investigators, and study
participants; and by implementing efficient and effective administrative operations and communication strategies.
Specific Aim 2: Strengthen and diversify the CTR workforce by identifying IPP and non-IPP investigators
for CTR careers; by enhancing the mentoring and professional development of CTR investigators and community
leaders; by supporting culturally responsive and scientifically meritorious CTR pilot projects; and by engaging
PBO/CBO to actively participate on all aspects of CTR.
Specific Aim 3: Disseminate and implement CTR findings by providing strategic investments in
PBO/CBO to strengthen trust-based relationships; by strengthening a statewide network of PBO/CBO to serve
as dissemination and implementation partners; by convening an annual conference that brings together CTR
investigators and PBO/CBO stakeholders to share best practices, discoveries, and dissemination and
implementation strategies; and by leveraging data science strategies to disseminate data and findings that are
user-friendly, easy to understand, and accessible.
By the end of this 5-year project, PIKO will have promoted high-impact transformative CTR to improve the
health of IPP and other marginalized communities in Hawaii.
太平洋创新,知识和机会中心(PIKO)将建立一个全州范围的临床和
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph Keawe'aimoku Kaholokula其他文献
Joseph Keawe'aimoku Kaholokula的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph Keawe'aimoku Kaholokula', 18)}}的其他基金
Strengthening Data Science Capacity for Biomedical Research Advancement at Hawaii
加强夏威夷生物医学研究进展的数据科学能力
- 批准号:
10872087 - 财政年份:2021
- 资助金额:
$ 300万 - 项目类别:
Center for Pacific Innovations, Knowledge, and Opportunities (PIKO)
太平洋创新、知识和机会中心 (PIKO)
- 批准号:
10685388 - 财政年份:2021
- 资助金额:
$ 300万 - 项目类别:
Center for Pacific Innovations, Knowledge, and Opportunities (PIKO)
太平洋创新、知识和机会中心 (PIKO)
- 批准号:
10474426 - 财政年份:2021
- 资助金额:
$ 300万 - 项目类别:
Cancer Research Education, Advancement, Training and Empowerment (CREATE) in the Pacific
太平洋地区的癌症研究教育、进步、培训和赋权 (CREATE)
- 批准号:
10226218 - 财政年份:2020
- 资助金额:
$ 300万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 300万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 300万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 300万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 300万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 300万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 300万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 300万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 300万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 300万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 300万 - 项目类别:
Standard Grant














{{item.name}}会员




